Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3035 EUR | 0.00% | -2.10% | -22.18% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.18% | 13.55M | |
+22.76% | 46.4B | |
-1.00% | 41.75B | |
+47.98% | 41.37B | |
-3.52% | 29.71B | |
+10.24% | 26.01B | |
-18.95% | 19.52B | |
+30.42% | 12.43B | |
+0.18% | 12.18B | |
-0.68% | 12.13B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Celyad Oncology Seeks Termination of Reporting Obligations to US SEC